🦊/Investors

Seaside Ventures2024 Investments

6 investments dated 2024 · listed companies and verified rows first · show all

Calorifycalorify.comin𝕏Oct 2024

Calorify measures individual metabolic rates and energy expenditure using doubly labeled water, a scientific method to quantify the calories people burn.

AI & Machine LearningDigital HealthHealthtechSports TechWellness & Fitness

Hari Mix(Founder & CEO)in

Co-investorsSanta Cruz VentureHealthtech CapitalLEAD

Next Life Sciencesnextlifesciences.orginSeed · Jan 2024 · $3M

Next Life Sciences works in reproductive healthcare, focused on solutions for couples.

BiotechFemTechHealthtech

L.R. Fox(Founder & Executive Chairman)Dr. Charles Carignan(Chief Medical Officer)Dr. Darlene Walley(Chief Executive Officer)Steve Bacich(President & COO)inDr. Bob Dudley(Chief Technology Officer)Dr. Rob Kellar(Chief Development Officer)

Co-investorsStreamlined VenturesUnruly CapitalMystic VenturesStartUp Health

Samphire Neurosciencesamphireneuro.cominPre-Seed · Feb 2024 · $2M

Samphire Neuro develops brain-based neurotechnology medical devices to treat chronic pain and mood conditions in women, targeting PMDD, dysmenorrhea, perimenopause, chronic migraines, and endometriosis.

Digital HealthFemTechMedical Devices

Emilė Radytė(CEO (Founder))inAlex Cook(COO (Founder))inErvinas Bern(CTO)inKendell Cannon(Chief Medical Officer)

Co-investorsAfterWork VenturesAlberts Impact VenturesAngel AcademeCVX VenturesFirstpickFortify Ventures+3 more

ZBioticszbiotics.comin𝕏Series A · Mar 2024 · $12M

Z Biotic develops genetically engineered probiotics designed to improve daily health and wellbeing.

BiotechConsumerHealthtechWellness & FitnessSan Francisco, US

Stephen Lamb(Founder)inZack Abbott(CEO)

Co-investorsAble PartnersBabel VenturesChampion Hill VenturesFundamental VenturesGoat Rodeo CapitalHyperguap+6 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Paterna BiosciencesUnlocked Labs

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.